Last updated at 29 Jul 2024 06:50 PM
Director
DIN: 05108499
Harbhajan Singh Rana is currently associated with 2 companies in various capacities such as Director and Individual Promoter. They serve as a Director at CHENAB FOODS PRIVATE LIMITED. and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 05108499.Harbhajan Singh Rana is currently involved in 2 different roles. Their most recent position is with PRABLAX DRUGS AND PHARMACEUTICAL PRIVATE LIMITED as a Individual Promoter. The first company Harbhajan Singh Rana was appointed to as a director was CHENAB FOODS PRIVATE LIMITED.. Harbhajan Singh Rana is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Harbhajan Singh Rana is currently associated with 2 companies in various capacities such as Director and Individual Promoter. They serve as a Director at CHENAB FOODS PRIVATE LIMITED. and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 05108499.Harbhajan Singh Rana is currently involved in 2 different roles. Their most recent position is with PRABLAX DRUGS AND PHARMACEUTICAL PRIVATE LIMITED as a Individual Promoter. The first company Harbhajan Singh Rana was appointed to as a director was CHENAB FOODS PRIVATE LIMITED.. Harbhajan Singh Rana is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
3
Male
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (0)
Past Companies (0)
4 Years 2 Years Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| CHENAB FOODS PRIVATE LIMITED. | Director | 30-Jan-2006 |
| PRABLAX DRUGS AND PHARMACEUTICAL PRIVATE LIMITED | Individual Promoter | 29-Jul-2022 |
| PRABLAX DRUGS AND PHARMACEUTICAL PRIVATE LIMITED | Director | 29-Jul-2022 |